首页> 外国专利> SCF -1 BISPECIFIC ANTIBODY TARGETING SCF AND GALECTIN-1 AND USE THEREOF

SCF -1 BISPECIFIC ANTIBODY TARGETING SCF AND GALECTIN-1 AND USE THEREOF

机译:SCF -1双特异性抗体靶向SCF和Galectin-1及其用途

摘要

The present invention relates to a dual target antibody targeting stem cell factors (SCFs) and galectin-1, and a composition for preventing or treating angiogenesis-related diseases containing the same. The present invention provides a dual target antibody derived from a human monoclonal antibody which neutralizes SCF and galectin-1 involved in angiogenesis at the same time to effectively inhibit angiogenesis; and a pharmaceutical composition for preventing or treating angiogenesis-related diseases containing the antibody. According to the present invention, the dual target antibody neutralizes two targets involved in angiogenesis at the same time such that a blood vessel is changed to abnormal angiogenesis to increase permeability, thereby effectively preventing or treating angiogenesis-related diseases causing bleeding.
机译:本发明涉及靶向干细胞因子(SCF)和半乳凝素-1的双重靶标抗体,以及用于预防或治疗包含它们的血管新生相关疾病的组合物。本发明提供了衍生自人单克隆抗体的双重靶标抗体,其同时中和参与血管生成的SCF和半乳凝素-1,以有效抑制血管生成。含有该抗体的用于预防或治疗血管新生相关疾病的药物组合物。根据本发明,双重靶标抗体同时中和参与血管生成的两个靶标,从而使血管变为异常血管生成以增加通透性,从而有效地预防或治疗引起出血的血管生成相关疾病。

著录项

  • 公开/公告号KR20190049483A

    专利类型

  • 公开/公告日2019-05-09

    原文格式PDF

  • 申请/专利权人 NOVELTY NOBILITY INC.;

    申请/专利号KR20180127615

  • 发明设计人 PARK SANG GYU;

    申请日2018-10-24

  • 分类号C07K16/24;G01N33/68;

  • 国家 KR

  • 入库时间 2022-08-21 11:51:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号